NasdaqCM - Delayed Quote USD

Tivic Health Systems, Inc. (TIVC)

0.4078 +0.0218 (+5.65%)
At close: June 7 at 4:00 PM EDT
0.3925 -0.02 (-3.75%)
After hours: June 7 at 7:37 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
1,134.0000
1,176.0000
1,840.0000
1,257.0000
860.0000
--
Cost of Revenue
793.0000
889.0000
1,541.0000
1,295.0000
1,085.0000
--
Gross Profit
341.0000
287.0000
299.0000
-38.0000
-225.0000
--
Operating Expense
7,951.0000
8,532.0000
10,397.0000
5,595.0000
2,979.0000
--
Operating Income
-7,610.0000
-8,245.0000
-10,098.0000
-5,633.0000
-3,204.0000
--
Net Non Operating Interest Income Expense
-154.0000
1.0000
2.0000
-1,823.0000
-423.0000
--
Other Income Expense
-1,278.0000
--
--
-1,038.0000
-12.0000
-60.0000
Pretax Income
-7,609.0000
-8,244.0000
-10,096.0000
-8,494.0000
-3,639.0000
--
Tax Provision
--
--
--
1.0000
--
2.0000
Net Income Common Stockholders
-7,609.0000
-8,244.0000
-10,096.0000
-8,494.0000
-3,639.0000
--
Diluted NI Available to Com Stockholders
-7,609.0000
-8,244.0000
-10,096.0000
-8,494.0000
-3,639.0000
--
Basic EPS
-0.89
-10.40
-104.32
-243.00
-39.28
--
Diluted EPS
-0.89
-10.40
-104.32
-243.00
-39.28
--
Basic Average Shares
1,109.6720
793.0430
96.7780
34.9320
92.6520
--
Diluted Average Shares
1,109.6720
793.0430
96.7780
34.9320
92.6520
--
Total Operating Income as Reported
-7,610.0000
-8,245.0000
-10,098.0000
-5,633.0000
-3,204.0000
--
Total Expenses
8,744.0000
9,421.0000
11,938.0000
6,890.0000
4,064.0000
--
Net Income from Continuing & Discontinued Operation
-7,609.0000
-8,244.0000
-10,096.0000
-8,494.0000
-3,639.0000
--
Normalized Income
-7,609.0000
-8,244.0000
-10,096.0000
-7,294.0000
-3,612.0000
--
Interest Income
--
1.0000
2.0000
--
--
--
Interest Expense
--
--
--
1,823.0000
423.0000
443.0000
Net Interest Income
-154.0000
1.0000
2.0000
-1,823.0000
-423.0000
--
EBIT
-7,610.0000
-8,245.0000
-10,098.0000
-6,671.0000
-3,216.0000
--
EBITDA
-7,426.0000
-8,063.0000
-9,924.0000
-6,647.0000
-3,208.0000
--
Reconciled Cost of Revenue
793.0000
889.0000
1,541.0000
1,295.0000
1,085.0000
--
Reconciled Depreciation
184.0000
182.0000
174.0000
24.0000
8.0000
--
Net Income from Continuing Operation Net Minority Interest
-7,609.0000
-8,244.0000
-10,096.0000
-8,494.0000
-3,639.0000
--
Total Unusual Items Excluding Goodwill
-1,281.0000
--
--
-1,200.0000
-27.0000
-75.0000
Total Unusual Items
-1,281.0000
--
--
-1,200.0000
-27.0000
-75.0000
Normalized EBITDA
-7,426.0000
-8,063.0000
-9,924.0000
-5,447.0000
-3,181.0000
--
12/31/2019 - 11/11/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

NUWE Nuwellis, Inc.
0.2110
-4.52%
 
BJDX Bluejay Diagnostics, Inc.
0.4330
-6.88%
 
HSDT Helius Medical Technologies, Inc.
1.2400
+5.08%
 
BBLG Bone Biologics Corporation
1.5400
-3.75%
 
SINT Sintx Technologies, Inc.
5.15
-12.27%
 
HSCS Heart Test Laboratories, Inc.
5.83
+1.04%
 
RSLS ReShape Lifesciences Inc.
0.2250
-3.93%
 
MDAI Spectral AI, Inc.
1.5500
-1.90%
 
AFIB Acutus Medical, Inc.
0.0453
+0.44%
 
INBS Intelligent Bio Solutions Inc.
1.9500
-6.70%